Introduction
Although reproductive performance is one of the most critical components in swine production, it has been one of the most difficult areas for geneticists and animal breeders to improve. Traditional quantitative methods such as selection, inbreeding and cross-breeding have had limited success in this area (Rothschild, 1996) . This is primarily due to the low heritabilities, sex-limited nature and insufficient phenotypic measurements for reproductive traits. Consequently, considerable variation exists for traits such as litter size, which currently ranges from approximately two to 40 pigs per litter, with average litter size ranging from nine to 16 depending on breed (Rothschild, 1996) . Therefore, litter size is very well suited for approaches based on marker-assisted selection.
Early investigations into the genetic basis of reproductive traits centred on the identification of blood groups and protein polymorphisms and their association with litter size. The estimation of potential pleiotropic effects of known major genes was also investigated. First evidence of such associations were obtained by Jensen et al. (1968) and Rasmusen and Hagen (1973) , who reported an association between the H locus on pig chromosome 6 and litter size with an unfavourable effect of the Ha allele. Kristjansson (1964) and Imlah (1970) reported an apparent effect of alleles at the transferrin locus (pig chromosome 13) on pig fertility and prolificacy. Unfortunately, the transferrin locus effect was not confirmed by other investigators (e.g. Jensen et al., 1968; Huang and Rasmusen, 1982) . Several other associations between blood group loci and reproductive traits have often led to contradictory results (e.g. Kennedy et al., 1973) . During the 1980s, there was considerable investigation of the role of the major histocompatibility complex (MHC) called the swine leukocyte antigen (SLA) complex on male and female reproductive traits. In the female, the MHC has been associated with ovulation rate (Rothschild et al., 1984; Conley et al., 1988) , litter size, number of pigs born alive and number weaned (reviewed in Vaiman et al., 1988) . For a complete review, see Warner and Rothschild (1991) . These results suggested a role for single genes in controlling litter size but results were indefinite at best. The results were freely published but the industry as a whole seemed reluctant to use this information in their breeding programmes, since the results were unclear and there was a lack of knowledge of how to implement such results.
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In the 1990s, three changes occurred which moved swine genetics research closer to a realization that commercialization and patenting was not only possible, but perhaps desirable. First and foremost was the advent of molecular biology that allowed an entirely different method of exploring the genetic differences for reproduction that existed within the domesticated pig. This allowed for the study of so-called 'candidate' genes that could be involved with biological processes such as reproduction and traits like litter size. This new approach was significantly more expensive than previous research and required larger investments than breeding companies had previously made for research. Second, biotechnology companies were becoming interested in animal agriculture and were willing to fund this high-risk/high-tech research. Thirdly, thanks to efforts by the USDA, University of Illinois, Iowa State University (ISU) and a number of pork producer's associations, Meishan pigs known for their exceptionally large litters were imported into the USA from China, providing exotic germplasm for new research. The scientific curiosity, the financial interest and the genetic material to better understand reproduction were now in position to attack the problem of improving reproduction through modern genetic methods.
Estrogen Receptor (ESR) -an Interesting Candidate Gene
In the 1980s, Rothschild and colleagues had begun to investigate the role of the MHC on pig chromosome 7 and reproduction. Rudimentary comparative maps (O'Brien, 1993) were beginning to be published that made it clear that the MHC complex was on human chromosome 6 but at this time the breakpoints of the comparative map were not known. In late 1990, with the Meishan pigs at Iowa State University, this team began to be interested in linked genes that could control reproduction. This work was further stimulated by a conversation with a colleague, Dr Carol Jacobson, about her work with a small South American opossum and the role that the estrogen receptor (ESR) played in reproduction (Handa et al., 1991) . The serendipity of this conversation cannot be overlooked. Noting that this gene was closely linked on the human gene map to the human MHC it was decided to investigate further. Using a human ESR gene probe, available at the time through the American Tissue Type Culture catalogue, the first Southern restriction fragment length polymorphism (RFLP) analysis was performed on pig DNA and showed a clear segregation of two fragments, 4.3 and 3.7 kb (see Fig.  11 .1, US Patent Number 5,374,526). These were called the A and B alleles. This allowed the gene to be mapped in the pig. Disappointingly for the hypothesis, the gene mapped to pig chromosome 1 not 7 (as had been predicted for linkage to MHC), but, on a hunch, the presence of these fragments was scored in 21 (of 22) Meishan females at ISU. The results were rather astounding as they showed a three-pig advantage to those with the A allele compared to those without it.
In an effort to obtain more funding and to pursue this interesting finding, it was decided to write a small industry grant. The grant was submitted to the National Pork Producer's Council with the preliminary results. Perhaps it was not too surprising that the significance of this (Rothschild et al., 1994) , was associated with improved litter size in a Meishan × Duroc composite line. The results were similar to the first ESR results obtained at ISU but there the important allele was the alternate A allele (see Table 11 .1). Based on what we now know, this difference was quite possibly real and is the result of different linkage between the polymorphism and a causative mutation (or quantitative brait loci, QTL -see also discussion below). However, it may simply be due to the small sample size in the ISU results with the apparent relationship being the result of chance. In the first stages of the research, there appeared to be an association within families, but not across the populations tested. These results, different associations between populations and between families, suggested a close linkage relationship between the marker and the causative mutation or QTL somewhere in the ESR region of pig chromosome 1. Nevertheless, the significant association of the ESR gene marker with litter size had real potential for commercial value and the patent application was pursued to protect the original invention of using ESR polymorphisms to improve litter size. It was also felt that a patent would provide additional support for these results in both the academic world and the marketplace. It should be noted that this work was initiated shortly after the identification and patenting of the method for testing and use of the 'Halothane' (HAL) gene. There was some debate in the scientific community as to the validity of the HAL patent, since the result seemed obvious once the gene became a candidate (see Fujii et al., 1991) . Indeed, the HAL invention was predicted in publications from the MacLennan group where they set out the strategy for finding the mutation (MacLennan et al., 1990) . However, this opinion was based, at least in part, on a misunderstanding of the term 'obviousness' as required for patentability. Even so, it was possible at that time to find different patent agents willing to support or condemn the HAL patent. It should be noted that, subsequently, this patent was granted in several different territories (e.g. US 5,358,649, 25 October 1994) . The ESR patent seemed less obvious and contrasted that of HAL, since despite the candidate gene approach no one had proven the role of genetic differences in the receptor and their relationship to litter size in the pig.
Later results (Rothschild et al., 1994 , again in Chinese pig crosses showed first parity differences between ESR homozygotes to be nearly 2.3 pigs per litter or an additive effect of an increase of 1.15 pigs per litter for each copy of the B allele (see Table 11 .1). In subsequent litters, the effect of the B allele was about 0.5 pigs per litter and appeared to act in a dominant manner. In one of the data sets, an interesting interaction was observed with parity. Although the B allele was generally found to be associated with larger litters across parities, it was actually found to be associated with a drop in litter size in parity two (results not shown). That is, litter size for BB sows was lower in parity two than either AA or AB sows. This was initially puzzling, but results from nutritional studies using Meishan crosses provided insight into what was happening here, indicating that it was related in part to a general drop in litter size in the second parity at that time. The nutritional regime being used in the research herd had not been adjusted sufficiently to manage the increased litter size obtained from these 'exotic' Meishan crosses (see, for example, Sinclair et al., 1999) . The BB gilts producing the largest litters in parity one were most susceptible to this deficiency. Once this requirement was recognized, this effect was dealt with so that in subsequent analyses females with the B allele were consistently producing larger litters. This is an interesting example of genotype by environment interaction (G×E) and shows how it is possible to manage these differences in situations where there is sufficient understanding of the system. It is also interesting, as several people still consider that G×E is a reason not to utilize gene markers.
The B allele was also found to be segregating in several Large White populations (Rothschild et al., 1995; Legault et al., 1996; Rothschild et al., 1996; Short et al., 1997) , in Chinese breeds and in a German synthetic line of Duroc and Large White origin (Drogemuller et al., 2001) , but the effect of the B allele seemed to differ somewhat between populations. However, in the largest study involving four commercial lines (Short et al., 1997) differences for the B allele were about 0.42 pigs per litter or a difference of 0.84 pigs per litter between the AA and BB homozygotes. The effect was only slightly smaller in later parities where the B allele showed more of a dominant effect than an additive effect (see Fig. 11 .1 and Table 11 .1). In this study, no real line differences were seen but then all of the lines had many litter records. It is possible that the differences seen in some studies may be due to the relatively small numbers included (see below for an alternative explanation). This study also demonstrated that there were no significant pleiotropic effects on growth that might impact the commercial value of its use to select for larger litters. Smaller studies on ESR have shown some apparent differences for the association with litter size but these may be the result of sampling (e.g. AA animals had larger litters than AB animals in a Polish study (Korwin-Kossakowska et al., 1999) , and in F2 females from a Large White Meishan cross the highest litter size was seen for heterozygotes with BB gilts having significantly smaller litters than AA or AB gilts ). It is also possible, however, that these line differences may either indicate that the ESR locus is only a linked marker or the differences in genetic backgrounds between lines have an impact on the expression of the ESR gene. To date a causative mutation has not been described.
Having invested in the technology, PIC continued to investigate how best to utilize the ESR gene. One key question was whether the effect of the beneficial B allele would be expressed in commercial crossbred sows. In order to test the hypothesis that ESR would explain variation in litter size in this situation, samples for marker testing were taken from commercial farms with reproductive performance recording. The sows used were produced from a cross, including one parent from the lines that showed an effect as presented by Short et al. (1997) . A total of 4493 sows producing 14,827 litters were sampled from nine farms. The frequency of the B allele was relatively low as the sow mothers were from a line essentially fixed for the A allele. Overall there was a difference of approximately 0.2 piglets between the litters of AA and AB sows (P < 0.01) with the heterozygous sows having the larger litters as predicted from the pure line results, although the size of the effect is about half that reported for the pure lines (Table 11 .1, Short, McLaren, Wilson and Plastow, unpublished results). Interestingly, there was a significant interaction with farm, with the size of the ESR effect tending to be larger the better the reproductive performance of the farm, and in one case the effect was in the opposite direction (i.e. the AB sows had smaller litters). One might speculate that this observation is related to the nutrition effect initially observed in Meishan crosses (see above), indeed, when analysed by parity the ESR effect was reduced in parity to two sows. These differences may explain the lower estimate for the size of the effect, but alternative explanations are also possible including epistatic effects. The smaller effect observed in this large data set was then used by PIC to estimate the value of the technology for the pro-ducer using cross-bred sows selected for ESR. An estimate of the value of the ESR marker test can be derived by considering the impact of fixing the preferred allele in a population. Here, we consider the impact in the USA for customers of PIC. The calculation needs to take into account the starting frequency of the allele, as well as the size of the effect. As we have shown above, the effect in commercial sows derived from PIC Large White pigs was on average around 0.2 pigs per litter per copy of the preferred B allele. The initial allele frequency was 0.5, so that if we assume that the allele is only derived from the Large White component of the cross (a reasonable assumption as the ESR marker is not segregating in Landrace lines that are used in the cross-bred sow), then the frequency of AB parent sows (commercial sows) would also be 0.5. If we assume that each sow will have five litters per lifetime and an additional pig per litter raised generates around $30 additional margin for the producer, then fixing ESR will generate an extra $30 per sow (0.2 pigs × 5 litters × $30). In 1996, PIC sold about 700,000 parent gilts in the USA, thus by fixing the gene in PIC Large White lines this would, given the gene frequency of 0.5, have been worth an extra $10.5 million to the US industry (0.5 × $30 × 700,000). Additional value would of course come from worldwide sales.
A Description of the Invention
The ESR patents are for genetic markers for litter size, methods for identifying such markers and methods for screening pigs to determine those more likely to produce larger litters and preferably selecting those pigs for future breeding purposes based on the ESR polymorphisms. The markers are based on the presence or absence of certain polymorphisms in the pig ESR gene. Preferably, the polymorphism is an RFLP polymorphism. The original application (Ser. No 07/687,708) was filed 19 April 1991, and was abandoned due to significant unresolved disagreements with the patent examiner and a failure of the original lawyers to describe the invention properly. A general observation is that patent examiners are somewhat lacking in general knowledge with respect to animal breeding and quantitative genetics. This was to be expected, as patents had not generally been filed in this field (see also Introduction), however, it presented some interesting challenges during the patent process for this gene. These problems were addressed by revision and refiling of the application. A continuation-in-part was filed on 19 October 1991 (Appl. No. 961,819). The first patent to be granted is US Patent No. 5,374,526 issued on 20 December 1994 and this was followed by US Patent No. 5,550,024 issued 27 August 1996 which was a continuation in part (C-I-P) of the earlier granted patent. This C-I-P was filed with a specific example of the use of polymerase chain reaction (PCR), which provided a more general approach and provided the basis for broader claims. In part, this was required, as the claims allowed by the examiner of US 5,374,526 were somewhat restricted. It should be noted that the filing of continuations is a specific difference between the US Patent Office and patent offices in other countries. It was possible to file a C-I-P to include the specific sequence of the polymorphism together with primers for PCR amplification of the region in order to broaden the coverage of the case. This would not have been possible, for example, in Europe and it is interesting to note that when the European application was eventually granted (EP No. 0580767, December 2000) the claims allowed were relatively broad and essentially as originally filed in the USA. Additional patents have been applied for and have been granted in various locations worldwide.
The original inventors were Max Rothschild and Carol Jacobson (see above), and David Vaske and Christopher Tuggle, as well as Alan Mileham and Graham Plastow at PIC for the C-I-P, where they contributed significantly with the creation of the marker test. Rights to market the technology are jointly owned by BRDC and ISU, who granted an exclusive licence to PIC for worldwide use of the technology. It should be noted that PIC strongly supported the project, were directly involved in the research, provided indirect funding for the research and finally participated in completing the invention for the US patent (see above).
The breadth of the coverage provided by the patent can probably only be determined in practise. At the time the patent was filed we considered that the invention related to the identification of the association between variation in the ESR region of the genome and variation in litter size, thereby providing the basis for using genetic markers to select for more prolific pigs. This can be interpreted to include other markers in the region (linked markers) that can be used for this purpose (as claimed). However, an analysis of this aspect is beyond the scope of this chapter and, in any case, we would anticipate that the nature of what is allowed will evolve over time as the field develops such that any view would not necessarily be generally applicable.
Research Implications
Implicit in the granting/publishing of a patent is that it will encourage future developments in the same field. Certainly this has been the case with the ESR patents. Since the discovery of the association of the ESR genotype with litter size, different groups have investigated this gene (see section describing ESR) and several other individual genes have been chosen for candidate gene studies for reproductive traits. In addition, there was an upsurge in the use of the candidate gene approach in pigs, although many groups have preferred to focus on the use of QTL analyses based on divergent crosses (see Rothschild and Soller, 1997 , for a discussion of the different approaches and in particular a defence of the candidate gene approach). Of course, as the amount of genome information increases, it is likely that the most efficient approach may be a combination of the two approaches (see Ciobanu et al., 2001) . Markers associated with growth and appetite, meat quality, muscling and coat colour have been identified and patents applied for (Kim et al., 2000; Milan et al., 2000; Nezer et al., 1999; Marklund et al., 1998) .
Examples of candidate gene work for litter size include retinol binding protein 4 (RBP4; Rothschild et al., 2000) , prolactin receptor (PRLR; Vincent et al., 1998) , and the gene encoding the beta subunit of follicle stimulating hormone (FSHB; Li et al., 1998) . These genes were selected due to their role in reproductive trait physiology. Additional patents have been filed and granted to cover these genes affecting litter size in the pig. These include prolactin receptor (PRLR), retinol binding protein 4 (RBP4) and FSHB under US Patent Nos 5, 935, 784, 5, 939, 264 and 6, 291, 174, respectively. Many studies have produced positive results with RBP4 Rothschild et al., 2000) , PRLR (Vincent et al., 1998; Drogemuller et al., 2000; Isler et al., 2000) and FSHB (Li et al., 1998; Huang et al., 2000) . Other research has had negative results (Linville et al., 2001) . However, in this study the number of pigs analysed for each genotype ranged from 189 (EGF) to 524 (PRLR) individuals, with litter size records taken only on 244 first-parity gilts. This sample population was likely insufficient in size to estimate accurately effects of the candidate genes. Short et al. (1997) indicated that over 1000 litter records were necessary to obtain a consistent estimate for the effect of ESR. So interpretation of results from small-scale association studies must always be done with care.
Early genome scans (Wilkie et al., 1996; Rohrer et al., 1999; Cassady et al., 2001) for reproductive traits have also been employed using crosses between Meishan and Large White breeds several QTL were found. These genome scans have been useful to identify regions of interest but they have not had the statistical power to find moderate to small effects. Furthermore, they have not had statistical power equal to most of the candidate gene analyses and therefore do not by themselves refute findings from larger candidate gene analyses involving several thousands of litter records. Interestingly, none of the QTL detected corresponded to the candidate genes discussed above. Finally, if ESR was segregating in these populations and at an intermediate allele frequency then there would not be the ability to find ESR gene effects in scans where ESR was not included in the analysis. It is unfortunate that researchers conducting these analyses have in general failed to understand the power of their experiments and other limitations that might have prevented them from seeing these candidate gene effects.
Responses from the Public and the Industry
In 1994, the ESR story was first told to a very large audience of interested researchers at the 5th World Congress on Genetics Applied to Livestock Production in Guelph, Canada. The first question, from a molecular geneticist was 'Why did you patent the marker test?', although, as has been noted, the first pig DNA marker was identified and patented by Canadian researchers in 1990 (Fujii et al., 1991) . Other questions reflected a real interest in the technology but some suggested doubt in the results and even disgust that industry was involved and a patent application had been filed. Clearly the most surprising and perhaps disappointing aspects of the ESR patent story for the inventors were some of the generally negative remarks received from some individuals. Although the exploitation of the invention has been a success (see below), these negative comments tended to get the most attention. Comments fell into several different groups, for example from wellmeaning and or naïve researchers concerned about patenting to researchers and industry personnel unhappy over the exclusivity of the licensing arrangement. Some of these responses are discussed below.
Supporters of the technology were intrigued by the candidate gene approach but had concerns about the statistical power of such an approach. Many researchers wondered if this was just a linkage effect. To date this and the fact that a causative mutation has not been made public continues to be a criticism of the patent. This misses the point that the invention is the identification of an association between polymorphisms in ESR and litter size so as to enable the selection of pigs with the potential for larger litters. The nature of the described polymorphism is irrelevant in this respect, although it is of genuine scientific interest and several groups have searched for additional polymorphisms within the gene (e.g. Drogemuller et al., 1997) .
The notoriety that the patent attracted caused many traditional animal breeders to take notice of patents and molecular biology. One group of respected university people expressed their concerns that academia should not be involved in a moneymaking enterprise. Furthermore, they felt that private appropriation of knowledge that had been generated in public institutions would erode the free flow of ideas. These can certainly be viewed as legitimate concerns (and are considered so by the authors) but they ignore the fact that university researchers get less money from public sources than they did several years ago, and the requirement to get more research dollars has changed how they operate. Farm animal research was catching up with the rest of biology in this respect. One of the intended aims of the patent system is specifically to stimulate the flow of ideas (or at least to provide access to new ideas) in a way that rewards inventive effort in terms of some form of commercial success.
Other individuals had complaints that DNA or animals could not be patented, and they questioned the exclusive nature of the patent/licensing agreement. The patenting of animals is not permitted in most of the major jurisdictions and this has not been attempted with the ESR patent. In livestock, other gene patents existed in 1994 but none had involved discoveries involving exotic germplasm. One Chinese researcher complained that the US researchers were 'exploiting' China by taking natural resources and patenting them. Whilst the Meishan breed was useful in the identification of the polymorphism, the breed itself was not subject to the patent claims. Clearly one of the misunderstandings was that the gene had been patented, whereas in this case a 'methods patent' had been granted that described the use of the gene, which is not restricted to the Meishan breed. This was a general source of misunderstanding for several years. Several discussions were held at industry meetings in Europe where opponents thought that the patent stopped them using their pigs if they carried the B allele of ESR so that they were determined to try to prevent patents on gene markers. This misunderstanding was eventually corrected and agreement on the value of such patents was reached among industry representatives.
Another well-respected animal breeder, Daniel Gianola, initiated an e-mail campaign (this story is provided with permission and encouragement by Dr Gianola) involving a character called Poul Henningsen, a Danish pig farmer that, writing in broken English, wanted to know if Prof. Roskilde could give him a discount for litter size genes. This e-mail spoof was to draw attention to concerns about the move from initial public release of results to patenting and did generate some useful exchange of ideas. Furthermore, Dr Gianola commented on other standard activities that animal breeders do including calculation of a mean and wondered if some scientist could have patented it. This argument is expanded in the accompanying review in this book by Schaeffer concerning the patenting of the test day model.
Perhaps the most disappointing aspect has been the limited research undertaken to explore or dispute the role of ESR in the reproductive processes. Even so, there have been some attempts (Isler et al., 1999a,b; Vonnahme et al., 1999; van Rens, 2001; van Rens et al., 2001) . One of the problems is the high cost and difficulty in undertaking this type of study, which in turn means that the size of such studies is very likely to be limited and experience suggests that relatively large numbers are required for studies of litter size. Vonnahme et al. (1999) reported that they could not find any evidence to support a role for ESR in controlling litter size, but small experiments of this type do not have the statistical power to declare 'no effect' of a gene. A larger research effort, although still restricted, was carried out by van Rens and van der Lende whose experiments looking at ESR (and also PRLR) investigated where in pregnancy ESR might exert its effect (van Rens, 2001 ). They con-cluded that the genes (or linked QTL) influenced different components of litter size. For ESR this was an effect on fetal survival (apparently from an effect on placental size); however, it should be noted that in one part of the study the A allele appeared to be associated with larger litters ). In the case of PRLR, the effect was on ovulation rate. Interestingly, Isler et al. (2000) also concluded that PRLR has a significant effect on number of embryos. This group also looked at the role of ESR and its relationship to the components of litter size, concluding that BB animals had 0.89 more fetuses per horn at day 75 of gestation than AA females (P<0.06) and other traits, including fetal survival, total uterine length, total fetal weight and ovulation rate within horn, also displayed favourable, but not statistically significant trends with respect to ESR BB genotype (Isler et al., 1999a,b) .
Those in the swine industry approached the discovery and patent with different viewpoints depending on whether they felt entitled to reap in the benefits or were threatened economically by the discovery. The Iowa Pork Producers Association fought a protracted battle with ISU claiming that their money, which helped allow importation of the Meishan pigs to ISU, gave them rights to a share of future income from the discovery. This disagreement was finally settled after they were shown that the discovery was independent of the pigs. Many swine genetics companies were understandably unhappy with the exclusivity of the licence agreement. One company told customers that 'it doesn't work -we tried it', which suggested that if they really had tested the genetic markers that they were infringing the patent. Another company's swine breeder noted that ESR was linked to the major gene for litter size and because of its exclusive licensing arrangement suggested attempting to avoid infringement by stating 'fortunately for others, there are several potentially alternative markers in the same region of the chromosome that are publicly available' (Webb, 1999) . As discussed earlier in the chapter, this point is open to interpretation, but the view expressed by Webb is counter to that of several experts in the field.
Conclusions
In the writing of this chapter, a number of thoughts surfaced relative to the ESR story that had been forgotten by the authors. Certainly the pressure to secure funding from BRDC and to get support from PIC made patenting a reasonable alternative to the usual university approach of 'write a grant that may or not be funded and then publish the work and see if anyone uses it'. At the time, a large factor in pursuing the patent was that it represented a first for Rothschild and his coinventors. It therefore had the positive feel of a new venture and provided new possibilities in the future for application of their work.
Another overriding fact was the desire to make clear that the discovery was unique and certainly a different result for animal breeding, in that a single gene had a large influence on a quantitative trait. Even today, ESR continues to be an interesting story from a scientific, industrial and personal basis. The commercialization of ESR led to it being awarded an R&D100 award in 1999, presented by the R&D magazine (September 1999, Vol. 41) which reviews inventions and their commercialization in the USA. This was a rare honour as most of the inventions recognized are not of a biological nature but more often engineering related. ESR continues to be marketed and customers of PIC from around the world are choosing both females and males with known ESR genotypes. Its success continues to grow and while there are detractors it still is one of the very few genetic markers associated with a quantitative trait. It has led to other genetic markers for litter size being discovered and most importantly to some rethinking of the notion that favourable alleles from single genes with large effects would be expected to be fixed in the population. Hopefully, this chapter gives a flavour for some of the difficulties and problems surrounding the patenting of this type of invention. Overall, despite these difficulties, the process has been a positive learning and rewarding experience.
